Condition: Liver Dysfunction · Sponsor: University of Alberta
INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and outcomes. A segment of a biopsy performed as standard-of-care for indications, or by center protocol, will be used for gene expression study.
This description comes directly from the study's public registry record.
Konrad S Famulski, PhD · 1 780 492 1725 · konrad@ualberta.ca
Robert Polakowski, PhD · 1 780 492 5091 · polakows@ualberta.ca
Always discuss trial participation with your own doctor first.
| University of California San Francisco, Transplant Research Unit | San Francisco, California, United States | Completed |
| Northwestern Memorial Hospital | Chicago, Illinois, United States | Completed |
| University of Maryland School of Medicine | Baltimore, Maryland, United States | Completed |
| Henry Ford Transplant Institute | Detroit, Michigan, United States | Recruiting |
| Vanderbilt University Medical Center, Vanderbilt Transplant Center | Nashville, Tennessee, United States | Withdrawn |
| Baylor University Medical Center, Annette C. and Harold C. Simmons Transplant Institute | Dallas, Texas, United States | Completed |
| Transplant Surgery, VCU Medical Center | Richmond, Virginia, United States | Completed |
| Division of Transplant Surgery, University of Washington | Seattle, Washington, United States | Completed |
| Centenary Institute of Cancer Medicine & Cell Biology, Royal Prince Alfred Hospital | Camperdown, Australia | Completed |
| University of Alberta, Laboratory Medicine and Pathology | Edmonton, Alberta, Canada | Completed |
| Dep. of Nephrology, Transplantation & Internal Med., Samodzielny Publiczny Szpital Kliniczny im. A. Mieleckiego | Katowice, Poland | Completed |
| Independent Public Composite Regional Hospital | Szczecin, Poland | Completed |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03193151